title: The endocannabinoid signaling system: a potential target for next-generation therapeutics for alcoholism.
abstract: Research into the endocannabinoid signaling system has grown exponentially in recent years following the discovery of cannabinoid receptors (CB) and their endogenous ligands, such as anandamide (AEA) and 2-arachidonoylglycerol (2-AG). Important advances have been made in our understanding of the endocannabinoid signaling system in various aspects of alcoholism, including alcohol-seeking behavior. Alcohol increases the synthesis or impairs the degradation of endocannabinoids, leading to a locally elevated endocannabinoid tone within the brain. Elevated endocannabinoid tone might be expected to result in compensatory down-regulation of CB1 receptors or dampened signal transduction. Following release, endocannabinoids diffuse back to the presynaptic neuron where they act as short-range modulators of synaptic activity by altering neurotransmitter release and synaptic plasticity. Mice treated with the CB1 receptor antagonist SR141716A (rimonabant) or homozygous for a deletion of the CB1 receptor gene exhibit reduced voluntary alcohol intake. CB1 knockout mice also show increased alcohol sensitivity, withdrawal, and reduced conditioned place preference. Conversely, activation of CB1 receptor promotes alcohol intake. Recent studies also suggest that elevated endocannabinoid tone due to impaired degradation contributes to high alcohol preference and self-administration. These effects are reversed by local administration of rimonabant, suggesting the participation of the endocannabinoid signaling system in high alcohol preference and self-administration. These recent advances will be reviewed with an emphasis on the endocannabinoid signaling system for possible therapeutic interventions of alcoholism.
authors: Division of Analytical Psychopharmacology, New York State Psychiatric Institute, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA. Basavaraj@nki.rfmh.org
authors: Balapal S
authors: BS
authors: Basavarajappa
mesh_terms: D000437:Alcoholism / Q000188:drug therapy*; D000818:Animals; D063385:Cannabinoid Receptor Modulators / Q000378:metabolism*; D063388:Endocannabinoids; D006801:Humans; D051379:Mice; D043882:Receptors, Cannabinoid / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects
chemical_list: D063385:Cannabinoid Receptor Modulators; D063388:Endocannabinoids; D043882:Receptors, Cannabinoid
references: Proc Biol Sci. 1998 Nov 7;265(1410):2081-5
references: 9842734
references: Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):235-42
references: 12052039
references: Neuropsychopharmacology. 2007 Jan;32(1):117-26
references: 16482090
references: Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):3662-5
references: 11259648
references: J Neurosci. 2003 Mar 15;23(6):2453-8
references: 12657705
references: Biochim Biophys Acta. 2000 Dec 15;1535(1):78-86
references: 11113634
references: J Pharmacol Exp Ther. 2002 Jun;301(3):1020-4
references: 12023533
references: Eur J Neurosci. 2001 Jul;14(2):342-52
references: 11553284
references: Recept Channels. 1999;6(5):363-74
references: 10551268
references: Prog Neurobiol. 2002 Apr;66(5):307-44
references: 12015198
references: Behav Brain Res. 2005 Nov 7;164(2):206-13
references: 16140402
references: Stroke. 2002 Aug;33(8):2112-4
references: 12154273
references: Eur J Pharmacol. 2003 Apr 11;466(1-2):73-83
references: 12679143
references: Neuropharmacology. 2004 Feb;46(2):243-53
references: 14680762
references: Mol Psychiatry. 2004 Oct;9(10):916-31
references: 15289816
references: Neurosci Lett. 2003 Jun 12;343(3):216-8
references: 12770700
references: J Biol Chem. 1996 Nov 15;271(46):29468-72
references: 8910614
references: Behav Pharmacol. 2002 Sep;13(5-6):451-63
references: 12394421
references: Alcohol. 1984 Mar-Apr;1(2):133-40
references: 6336143
references: Eur J Pharmacol. 1998 Jan 2;341(1):39-44
references: 9489854
references: Annu Rev Neurosci. 1996;19:319-40
references: 8833446
references: Chem Phys Lipids. 2000 Nov;108(1-2):123-34
references: 11106786
references: Science. 2002 Apr 26;296(5568):678-82
references: 11976437
references: J Neurosci Res. 2001 May 15;64(4):429-36
references: 11340650
references: Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8384-8
references: 12060781
references: Science. 1997 Aug 22;277(5329):1094-7
references: 9262477
references: Alcohol Res Health. 2002;26(3):193-201
references: 12875047
references: Psychopharmacology (Berl). 1997 Jul;132(1):104-6
references: 9272766
references: Zhongguo Yao Li Xue Bao. 1999 Dec;20(12):1109-14
references: 11189201
references: Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14136-41
references: 10570211
references: Proc Natl Acad Sci U S A. 1990 Mar;87(5):1932-6
references: 2308954
references: J Neurosci. 2000 Jan 1;20(1):51-8
references: 10627580
references: Nature. 1970 May 23;226(5247):701-4
references: 5443246
references: Br J Pharmacol. 2004 Oct;143(4):455-64
references: 15371286
references: Mol Pharmacol. 2000 Oct;58(4):814-20
references: 10999952
references: Nature. 1996 Nov 7;384(6604):83-7
references: 8900284
references: Science. 1996 Sep 20;273(5282):1719-22
references: 8781236
references: Neuroscience. 2003;119(2):481-96
references: 12770562
references: Eur J Biochem. 2001 Apr;268(7):1982-9
references: 11277920
references: Neuroscience. 1998 Jul;85(2):395-403
references: 9622239
references: J Neurochem. 1997 Aug;69(2):631-8
references: 9231721
references: J Neurophysiol. 2001 Jul;86(1):40-8
references: 11431486
references: Am J Pharmacogenomics. 2003;3(4):217-32
references: 12930156
references: J Neurochem. 1999 Sep;73(3):1084-9
references: 10461898
references: Brain Res. 2002 Nov 1;954(1):73-81
references: 12393235
references: J Neurosci. 1999 Jun 1;19(11):4544-58
references: 10341254
references: Crit Rev Neurobiol. 1999;13(3):243-81
references: 10803637
references: Proc Natl Acad Sci U S A. 1988 Jul;85(14):5274-8
references: 2899326
references: Neuropharmacology. 2006 Jun;50(7):834-44
references: 16448676
references: Nature. 1970 Sep 12;227(5263):1151-2
references: 4915993
references: Prog Neurobiol. 1998 Nov;56(4):385-431
references: 9775400
references: Biochem Pharmacol. 1998 Feb 15;55(4):515-21
references: 9514087
references: J Neurosci. 1999 May 1;19(9):3277-86
references: 10212287
references: Nature. 1997 Aug 21;388(6644):773-8
references: 9285589
references: Prostaglandins Other Lipid Mediat. 2002 Aug;68-69:619-31
references: 12432948
references: J Biol Chem. 1995 Jun 9;270(23):13973-80
references: 7775459
references: Prog Neuropsychopharmacol Biol Psychiatry. 2004 Dec;28(8):1221-47
references: 15588749
references: Brain Res. 1998 Aug 17;802(1-2):19-26
references: 9748483
references: Psychopharmacology (Berl). 1999 Mar;142(3):302-8
references: 10208323
references: Neurosci Lett. 1993 Sep 3;159(1-2):83-7
references: 7505417
references: Mol Pharmacol. 1994 Sep;46(3):516-22
references: 7935333
references: Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):287-99
references: 12052043
references: Biochem J. 1995 Dec 1;312 ( Pt 2):637-41
references: 8526880
references: J Neurosci. 2004 Dec 8;24(49):11070-8
references: 15590923
references: Chem Phys Lipids. 2000 Nov;108(1-2):53-70
references: 11106782
references: Alcohol Clin Exp Res. 2005 Aug;29(8):1504-13
references: 16156047
references: Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11891-6
references: 15280536
references: Chem Phys Lipids. 2000 Nov;108(1-2):107-21
references: 11106785
references: J Pharmacol Exp Ther. 1993 Apr;265(1):218-26
references: 8474008
references: Nature. 1993 Sep 2;365(6441):61-5
references: 7689702
references: Br J Pharmacol. 1999 Jun;127(4):935-40
references: 10433501
references: FASEB J. 2001 Feb;15(2):300-2
references: 11156943
references: Neuropsychopharmacology. 2005 Feb;30(2):339-49
references: 15383833
references: Neurosci Lett. 1998 Oct 2;254(3):137-40
references: 10214976
references: Proc Natl Acad Sci U S A. 1999 May 11;96(10):5802-7
references: 10318965
references: Alcohol Alcohol. 1998 Mar-Apr;33(2):126-30
references: 9566474
references: Alcohol Clin Exp Res. 2005 Nov;29(11 Suppl):102S-109S
references: 16344593
references: Nature. 1998 Dec 17;396(6712):636-7
references: 9872309
references: Pharmacol Biochem Behav. 2005 Jun;81(2):263-84
references: 15936806
references: Biochem Biophys Res Commun. 1999 Mar 16;256(2):377-80
references: 10079192
references: Eur J Neurosci. 2005 Apr;21(8):2243-51
references: 15869521
references: Neuroscience. 2002;113(3):671-82
references: 12150787
references: J Biol Chem. 1998 Nov 27;273(48):32332-9
references: 9822713
references: Biochem Pharmacol. 1995 Jun 29;50(1):83-90
references: 7605349
references: Proc Natl Acad Sci U S A. 1986 Apr;83(7):2105-8
references: 3008152
references: J Neurochem. 2003 Feb;84(4):698-704
references: 12562514
references: FEBS Lett. 1999 Apr 16;449(1):61-5
references: 10225429
references: Mol Pharmacol. 2001 Jul;60(1):155-63
references: 11408610
references: Am J Physiol. 1999 Jun;276(6):H2085-93
references: 10362691
references: Science. 1992 Dec 18;258(5090):1946-9
references: 1470919
references: Mol Pharmacol. 1998 Nov;54(5):834-43
references: 9804618
references: Nat Neurosci. 2002 May;5(5):446-51
references: 11976704
references: J Neural Transm (Vienna). 2000;107(6):613-38
references: 10943904
references: Brain Res. 2001 Dec 7;921(1-2):240-55
references: 11720732
references: Alcohol Clin Exp Res. 2002 Apr;26(4):565-74
references: 11981134
references: Neuroscience. 2000;97(1):89-97
references: 10771342
references: J Neurosci. 2001 Jan 1;21(1):109-16
references: 11150326
references: Eur J Heart Fail. 2004 Jun;6(4):501-8
references: 15182777
references: J Neurochem. 1999 Feb;72(2):522-8
references: 9930723
references: Nature. 1994 Dec 15;372(6507):686-91
references: 7990962
references: Alcohol Alcohol. 2004 Jul-Aug;39(4):297-302
references: 15208160
references: FEBS Lett. 1995 Feb 13;359(2-3):133-6
references: 7867785
references: Pharmacol Toxicol. 2001 Apr;88(4):213-22
references: 11322181
references: Alcohol Clin Exp Res. 2001 Feb;25(2):277-82
references: 11236843
references: Nat Neurosci. 1999 Apr;2(4):358-63
references: 10204543
references: Alcohol Clin Exp Res. 2001 Sep;25(9):1317-23
references: 11584151
references: Mol Pharmacol. 2001 Jun;59(6):1369-75
references: 11353795
references: Brain Res. 1998 May 18;793(1-2):212-8
references: 9630633
references: Eur J Pharmacol. 1999 Apr 16;370(3):233-40
references: 10334497
references: Pharmacol Rev. 2002 Jun;54(2):161-202
references: 12037135
references: Drug Alcohol Depend. 2002 Mar 1;66(1):77-84
references: 11850139
references: Neurochem Int. 2006 Nov;49(6):619-25
references: 16822589
references: J Neurosci. 2004 Jan 7;24(1):53-62
references: 14715937
references: J Neurosci. 1991 Feb;11(2):563-83
references: 1992016
references: Neuroreport. 2000 Apr 27;11(6):1231-5
references: 10817598
references: Curr Opin Neurobiol. 1996 Apr;6(2):228-36
references: 8725965
references: Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1393-8
references: 12538878
references: J Neurosci. 1997 Feb 15;17(4):1226-42
references: 9006968
references: Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3376-80
references: 7724569
references: Alcohol Clin Exp Res. 1980 Jul;4(3):288-93
references: 6996514
references: Nat Med. 2006 Jun;12(6):671-6
references: 16715087
references: J Neurosci Res. 2000 Apr 1;60(1):122-8
references: 10723075
references: Biochem Biophys Res Commun. 1995 Oct 4;215(1):89-97
references: 7575630
references: Neuroreport. 1994 Jun 2;5(10):1265-8
references: 7919180
references: Eur J Pharmacol. 1998 Oct 16;359(1):1-18
references: 9831287
references: J Neurochem. 2000 Dec;75(6):2434-44
references: 11080195
references: Trends Pharmacol Sci. 2003 Jun;24(6):266-8
references: 12823949
references: Psychopharmacology (Berl). 2002 Jan;159(2):181-7
references: 11862347
references: Alcohol Clin Exp Res. 1997 Oct;21(7):1199-203
references: 9347079
references: Brain Res. 1999 Jan 2;815(1):89-97
references: 9974126
references: Psychopharmacology (Berl). 2006 Jan;183(4):394-403
references: 16261315
references: J Neurosci. 1997 May 15;17(10):3946-55
references: 9133412
references: Learn Mem. 2000 May-Jun;7(3):132-9
references: 10837502
references: Science. 1997 Jun 27;276(5321):2048-50
references: 9197269
references: J Neurophysiol. 2001 Jan;85(1):468-71
references: 11152748
references: J Pharmacol Exp Ther. 2001 Jul;298(1):7-14
references: 11408519
references: J Biol Chem. 2001 Oct 12;276(41):38289-96
references: 11468287
references: Physiol Rev. 1997 Jan;77(1):1-20
references: 9016298
references: J Neurosci. 2002 May 1;22(9):3332-7
references: 11978808
references: Eur J Pharmacol. 2002 May 17;443(1-3):95-7
references: 12044797
references: Eur J Pharmacol. 2001 Nov 2;430(2-3):369-71
references: 11711056
references: Biochem J. 2000 Apr 15;347(Pt 2):369-73
references: 10749665
references: Arch Gen Psychiatry. 1983 Apr;40(4):435-42
references: 6838323
references: Hypertension. 1999 Jan;33(1 Pt 2):429-34
references: 9931142
references: J Biol Chem. 2001 Mar 9;276(10):6967-73
references: 11118429
references: Lancet. 2005 Apr 16-22;365(9468):1389-97
references: 15836887
references: Mol Pharmacol. 2005 Nov;68(5):1196-202
references: 16051747
references: Life Sci. 1999;65(6-7):657-64
references: 10462066
references: Psychol Rev. 1987 Oct;94(4):469-92
references: 3317472
references: Biochem Pharmacol. 1994 Feb 11;47(4):711-5
references: 8129747
references: Alcohol Alcohol. 2004 Mar-Apr;39(2):88-92
references: 14998822
references: J Neurochem. 2006 Oct;99(1):308-20
references: 16987253
references: Mol Pharmacol. 2000 Feb;57(2):288-95
references: 10648638
references: J Neurophysiol. 2000 Jun;83(6):3287-93
references: 10848548
references: Mamm Genome. 1998 Dec;9(12):927-8
references: 9880654